Journey inks $20M buyout of topical medicines
To view this email as a web page, click here

Today's Rundown

Featured Story

GSK, Vir file for emergency FDA authorization of intramuscular formulation of COVID-19 antibody

GlaxoSmithKline and Vir Biotechnology have taken a big step toward authorization of an intramuscular formulation of their anti-SARS-CoV-2 antibody sotrovimab. The partners have filed for FDA emergency use authorization of a more convenient form of one of the few antibodies to hold up against omicron.

read more

Top Stories

Chasing Pfizer, Antares advances rescue med into pivotal trial

Antares Pharma is stepping up its pursuit of Pfizer. Having taken a rescue pen rival to Pfizer’s Solu-Cortef through a phase 1 study, Antares is preparing for a pivotal clinical trial designed to support a filing for FDA approval by the end of the year.

read more

Journey of Vyne's topical drugs continues with $20M deal

Journey Medical is taking control of a topical drug delivery platform and three drugs based on the technology. The dermatology specialist is paying Vyne Therapeutics $20 million upfront to take control of two approved drugs, Amzeeq and Zilxi, along with an investigational candidate.

read more

Stanford spinout forms drug delivery joint venture with Chinese biotech

Stanford University spinout N1 Life has formed a joint venture to further its drug delivery ambitions. The startup is teaming up with Accuredit Therapeutics to create a joint venture, Napoltec, focused on novel drug delivery systems and the progression of drug candidates toward clinical translation.

read more

The top 10 medtech M&A deals of 2021

Many of 2021's medtech acquisitions were fueled by pandemic windfalls, driven by a year of roller-coaster demand for coronavirus diagnostics and supplies.

read more

The top 10 biopharma M&A deals in 2021

Biopharma merger and acquisition (M&A) activity was subdued in 2021 and would have approached a record low for recent years if not for a flurry of deals in the last quarter.

read more

Resources

Whitepaper: Tailored, Dedicated Support Expedites COVID-19 Vaccine Trial

Sites receiving augmentation support enroll more than 30,000 patients in just over three months. See how additional site resources can make a difference.

Research: How Buffer Prep Services Alleviate Sudden Spikes in Campaign Volume

Learn how a CDMO partnered with Thermo Fisher Scientific to manage high-volume process liquid and buffer preparation scale-up. Download the free case study from Thermo Fisher Scientific

Whitepaper: QC for ex vivo manipulated cell lines and tissues

A variety of genetic analysis methods are valuable in ensuring that ex vivo human cells to be used for cell-based therapies are correctly identified, have the correct characteristics, and are free of contaminants.

Webinar: Using Next Best to Elevate your Omnichannel Marketing Strategy

Learn how to elevate your omnichannel marketing strategy with Next Best - a combination of data and analytics, deployed to facilitate decision making.

Webinar: The Faster Path From Pre-Filled Syringe to Auto-Injector

Ypsomed and Catalent Biologics experts discuss strategies for integrated PFS manufacturing and auto-injector assembly to accelerate timelines and more in this webinar.

Whitepaper: Formulation Strategies When Transitioning From Vial to PFS

Learn how formulation development for a PFS affects manufacturing to drive the industry toward optimizing delivery of injectable products and, ultimately, improving patient care.

Whitepaper: Enhance the cost-effectiveness of your cGMP chemical supply chain

Learn how to develop a high-performing supply chain for cGMP chemicals used throughout your biologics workflow. Download the free whitepaper from Thermo Fisher Scientific

eBook: Get solutions to market faster

Read Get to Know Cloud Content Management for Life Sciences and learn how to eliminate silos across all workflows, from R&D to commercialization.

Events